Baxter in Talks to Acquire Hill-Rom for ~$10B
Shots:
- Baxter in talks to acquire Hill-Rom for ~$10B with $150/ share representing a premium of 13% to the stock’s closing price of $132.90. The acquisition is expected to be announced later this week
- The decision follows an earlier bid in which Hill-Rom had turned down Baxter’s previous offer of $144/ share with a total value of ~$9.6B
- Hill-Rom offers a wide range of medical devices and hospital equipment including patients beds for ICU and long-term care to vital sign monitors and wearable electrocardiogram hardware
| Ref: Reuters | Image: LinkedIn
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com